Tampa Bay Adult Congenital Heart Disease Clinic presents

Heart Health through EducationThis website is certified by Health On the Net Foundation. Click to verify.

Home Tampa Bay ACHD Our Providers

 

Home
Up
Heart News
Heart Links
Helpful Information
Heart Events
Patient Page
Cardiac Services
Special Clinics
Fun Heart Facts
Fun Heart Quotes
Clinical Research
Privacy Policy
Locate Us

 

This website is certified by Health On the Net Foundation. Click to verify.   

 

We subscribe to the

HON code principles.

 HONConduct183486

Initial accreditation July 2005

 Updated Sept 2011

     

 

 

                                       

 

Atrial Fibrillation Part II
 

Hector Fontanet, M.D., FACC
with Marie Cheine, Medical Writer

August 26, 2005

In our last article, we discussed atrial fibrillation, the most common form of irregular heart rhythm. The goals of treatment for atrial fibrillation are prevention of stroke, control of heart rate and restoration of normal rhythm. As previously reported, the prevention of stroke in nearly all patients with atrial fibrillation will be necessary. This is carried out by the anticoagulation (blood thinning) with Coumadin® or Warfarin. It has been shown in clinical trials that treatment with aspirin is not sufficient to prevent stroke in this class of patients. Common medications for rate control include calcium channel blockers, beta-blockers and digoxin. Although this group of medications is effective in controlling the heart rate they are not usually effective in restoring normal heart rhythm. Medications that convert and maintain normal rhythm are called antiarrhythmics. Long term options for treatment are dependent upon the underlying cause (etiology) of each individual case.

Based on the results recently learned from various clinical trials, most asymptomatic patients will be best managed with rate control and anticoagulation only, avoiding potential side effects of antiarrhythmics. However, some patients remain symptomatic after rate is controlled. For these patients, or patients who have underlying heart disease, the use of antiarrhythmics has advantages, most importantly the improvement of quality of life, improving heart function in patients with heart failure and potentially allowing the discontinuation of anticoagulation therapy.

Antiarrhythmics, nevertheless, are a complex class of medications and carry risk and potential side effects. The most effective medication in this class is Amiodarone, which works by slowing nerve impulses in the heart and acting directly on the heart cells to synchronize the electrical impulses. These medications should be used judiciously and patients must be closely monitored while using them. In some cases, these medications can cause life threatening rhythm disturbances in patients with certain heart conditions. For this reason, your doctor may elect to start this type of medication in the hospital under careful observation.

In cases where symptoms or side effects remain intolerable or a patient fails medical therapy, other therapies such as electrical cardioversion (electric shock to restore normal rhythm) or radiofrequency ablation can be considered. Radiofrequency ablation is an invasive procedure performed in the hospital in the cardiac catheterization laboratory. During this procedure, x-rays are utilized to position a special catheter at the exact place in the heart where the abnormal rhythm is generated and “microwave-like” energy is transmitted to destroy this area and prevent the abnormal rhythm. Radiofrequency ablation is only performed by electrophysiologists who have special training in this procedure. Your physician can refer you to an electrophysiologist with this expertise if necessary.

In summary, atrial fibrillation is a common non life threatening rhythm disturbance of the heart. The approach for treatment varies with each patient. Whether it is rate control or restoration of normal rhythm, with any one of many modalities, the risks and benefits of medical and/or invasive treatment must be weighed carefully and discussed in detail with your physician.

Sources:

American Heart Association
Cleveland Clinic Journal of Medicine
Electrophysiology Division University of California San Francisco
Heart Rhythm Society
Medline Plus